VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,567 | -1.1% | 120,733 | +50.9% | 0.00% | – |
| Q2 2023 | $527,160 | -51.2% | 79,994 | -49.7% | 0.00% | – |
| Q1 2023 | $1,079,922 | +96.0% | 159,046 | +113.3% | 0.00% | – |
| Q4 2022 | $550,954 | -0.7% | 74,554 | +32.8% | 0.00% | – |
| Q3 2022 | $555,000 | -5.3% | 56,149 | +4.4% | 0.00% | – |
| Q2 2022 | $586,000 | -4.1% | 53,790 | -0.4% | 0.00% | – |
| Q1 2022 | $611,000 | +3494.1% | 54,011 | +4947.8% | 0.00% | – |
| Q4 2021 | $17,000 | -5.6% | 1,070 | -0.7% | 0.00% | – |
| Q3 2021 | $18,000 | -21.7% | 1,078 | 0.0% | 0.00% | – |
| Q2 2021 | $23,000 | +1050.0% | 1,078 | +978.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 100 | -33.3% | 0.00% | – |
| Q2 2020 | $2,000 | -99.9% | 150 | -99.9% | 0.00% | – |
| Q1 2020 | $2,411,000 | -36.9% | 232,692 | -0.0% | 0.00% | – |
| Q4 2019 | $3,819,000 | -27.8% | 232,775 | -41.6% | 0.00% | -100.0% |
| Q3 2019 | $5,292,000 | -30.3% | 398,475 | -26.1% | 0.00% | 0.0% |
| Q2 2019 | $7,594,000 | -47.7% | 538,975 | -31.7% | 0.00% | -50.0% |
| Q1 2019 | $14,514,000 | -43.8% | 788,809 | -20.2% | 0.00% | -50.0% |
| Q4 2018 | $25,824,000 | +0.8% | 988,288 | -11.5% | 0.00% | +33.3% |
| Q3 2018 | $25,623,000 | +2.6% | 1,116,454 | -14.9% | 0.00% | 0.0% |
| Q2 2018 | $24,984,000 | +13.1% | 1,311,471 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,098,000 | +10.9% | 1,311,471 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $19,934,000 | -25.0% | 1,311,471 | -11.6% | 0.00% | -33.3% |
| Q3 2017 | $26,570,000 | +1.8% | 1,484,371 | -7.3% | 0.00% | 0.0% |
| Q2 2017 | $26,099,000 | +16.4% | 1,601,171 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $22,416,000 | +41.1% | 1,601,171 | +60.7% | 0.00% | +50.0% |
| Q4 2016 | $15,891,000 | +885.2% | 996,271 | +928.0% | 0.00% | – |
| Q3 2016 | $1,613,000 | +146.6% | 96,913 | +23.9% | 0.00% | – |
| Q1 2016 | $654,000 | -53.2% | 78,200 | -47.9% | 0.00% | – |
| Q4 2015 | $1,397,000 | -94.9% | 150,078 | -94.9% | 0.00% | -100.0% |
| Q1 2015 | $27,485,000 | -62.0% | 2,955,429 | -41.4% | 0.00% | -55.6% |
| Q4 2014 | $72,262,000 | +52.3% | 5,046,196 | +10.4% | 0.01% | +50.0% |
| Q3 2014 | $47,438,000 | -35.8% | 4,570,120 | +0.0% | 0.01% | -40.0% |
| Q2 2014 | $73,934,000 | +0.8% | 4,569,496 | +1.2% | 0.01% | 0.0% |
| Q1 2014 | $73,370,000 | +69.2% | 4,515,096 | +29.2% | 0.01% | +66.7% |
| Q4 2013 | $43,357,000 | +22.6% | 3,493,700 | +8.4% | 0.01% | +20.0% |
| Q3 2013 | $35,365,000 | +411.7% | 3,223,800 | +276.9% | 0.01% | +400.0% |
| Q2 2013 | $6,911,000 | – | 855,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |